ANP Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK - 27th Jun 2023, 3:46pm

annb0t

annb0t

Top 20
ANP Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK
Price Sensitive: Y
Date: 27th Jun 2023, 3:46pm

>>> Read announcement: Google: ANP Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
ANP Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 31st Oct 2023, 9:38am
Replies
0
Views
94
annb0t
annb0t
annb0t
ANP Ann: Change in substantial holding - 17th Oct 2023, 2:11pm
Replies
0
Views
75
annb0t
annb0t
annb0t
ANP Ann: Notice of Annual General Meeting/Proxy Form - 17th Oct 2023, 9:21am
Replies
0
Views
83
annb0t
annb0t
annb0t
ANP Ann: Antisense to participate in upcoming investor conferences - 16th Oct 2023, 8:22am
Replies
0
Views
83
annb0t
annb0t
annb0t
ANP Ann: Antisense launches Unmarketable Parcels facility - 9th Oct 2023, 8:26am
Replies
0
Views
64
annb0t
annb0t
Top Bottom